TY  - JOUR

T1  - Pragmatic health technology appraisals of biosimilars: a pilot case study of bevacizumab in colorectal cancer for NICE

JO  - Cost Effectiveness and Resource Allocation

UR  - https://doi.org/10.1186/s12962-026-00761-w

PY  - 2026/05/12

AU  - Stevenson MD

AU  - Mon-Yee M

AU  - Forsyth JE

AU  - Montazeri A

AU  - Saunders MP

ED  - 

DO  - DOI: 10.1186/s12962-026-00761-w

PB  - Springer Science and Business Media LLC

Y2  - 2026/05/25

ER  -